Moreover, the combination of high MMP-1 and PICP levels predicted a poor outcome in DCM patients, beyond LGE and other well-known predictors of outcome (age, sex, LVEF, NYHA ≥ 3, and NTproBNP). The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.